Correlation Between Xbrane Biopharma and Vicore Pharma
Can any of the company-specific risk be diversified away by investing in both Xbrane Biopharma and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xbrane Biopharma and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xbrane Biopharma AB and Vicore Pharma Holding, you can compare the effects of market volatilities on Xbrane Biopharma and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xbrane Biopharma with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xbrane Biopharma and Vicore Pharma.
Diversification Opportunities for Xbrane Biopharma and Vicore Pharma
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Xbrane and Vicore is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Xbrane Biopharma AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and Xbrane Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xbrane Biopharma AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of Xbrane Biopharma i.e., Xbrane Biopharma and Vicore Pharma go up and down completely randomly.
Pair Corralation between Xbrane Biopharma and Vicore Pharma
Assuming the 90 days trading horizon Xbrane Biopharma AB is expected to under-perform the Vicore Pharma. In addition to that, Xbrane Biopharma is 2.05 times more volatile than Vicore Pharma Holding. It trades about -0.28 of its total potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.15 per unit of volatility. If you would invest 828.00 in Vicore Pharma Holding on August 29, 2024 and sell it today you would lose (52.00) from holding Vicore Pharma Holding or give up 6.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xbrane Biopharma AB vs. Vicore Pharma Holding
Performance |
| Timeline |
| Xbrane Biopharma |
| Vicore Pharma Holding |
Xbrane Biopharma and Vicore Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xbrane Biopharma and Vicore Pharma
The main advantage of trading using opposite Xbrane Biopharma and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xbrane Biopharma position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.| Xbrane Biopharma vs. Hansa Biopharma AB | Xbrane Biopharma vs. Vicore Pharma Holding | Xbrane Biopharma vs. XSpray Pharma AB | Xbrane Biopharma vs. Saniona AB |
| Vicore Pharma vs. Hansa Biopharma AB | Vicore Pharma vs. Xbrane Biopharma AB | Vicore Pharma vs. BioArctic AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |